Pulmonary arterial hypertension and systemic lupus erythematosus Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011
Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018 Year: 2019
Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016
Pulmonary hypertension in systemic lupus erythematosus – a retrospective analysis Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009
Raynaud phenomenon is correlated with systolic pulmonary arterial pressure in patients with systemic lupus erythematosus Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006
Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE) Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020
The nitroxidergic system state at systemic lupus erythematosus-associated pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study Source: ERJ Open Res, 4 (1) 00135-2017; 10.1183/23120541.00135-2017 Year: 2018
Prevalence of pulmonary hypertension in patients with plasma lupus anticoagulant Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006
The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003
Cardio-pulmonary exercise testing in systemic lupus erythematosus patients Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Lung abnormalities in patients with systemic lupus erythematosus Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001
Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007
Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies? Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007
Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010
Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease Source: Eur Respir Monogr 2019; 86: 106-123 Year: 2019